MGMT and malignant glioma: Methylation of the MGMT gene promoter occurs in 35–45% of malignant gliomas [56], and it has been associated with decreased expression of O6-methylguanine-DNA methyltransferase (MGMT), an enzyme that reduces DNA damage [172].